Company intelligence / Profile preview

Cormorant Capital

New York City, New York, United States

Ownership: Private
Development stage: Other

Overview

Cormorant Capital is a New York-based finance company specializing in sourcing equity solutions and providing capital to real estate operators, focusing on multifamily, industrial, and self-storage sectors. It co-invests and partners with existing owners to enhance operational capabilities and supports growth through value-add and opportunistic strategies. There is no public evidence that Cormorant Capital operates in life sciences, biotech, pharma, or healthcare as a primary focus.

Industry: Investors

Beyond the preview

Go deeper on Cormorant Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cormorant Capital.

Explore the full profile